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Abstract 20 
Introduction: 21 
The VisiTag module (CARTO3) provides an objective assessment of radiofrequency (RF) ablation 22 
parameters. This study aimed to determine the predictive value and optimal VisiTag threshold settings for 23 
prediction of gaps in mature atrial scar, as assessed non-invasively using cardiac magnetic resonance (CMR) 24 
imaging.  25 
Methods: 26 
24 subjects (11 paroxysmal AF) underwent first-time RF ablation with operators blinded to VisiTag data. 3D 27 
LGE CMR scans were performed at 3 months (1.3x1.3x4mm3). A survey of UK operators defined standard 28 
VisiTag settings (‘Force’ 8g, ‘Time’ 10seconds, ‘Percentage Time’ 50%, ‘Range’ 3mm, ‘Impedance’ and 29 
‘Temperature’ ‘off’). Each ablation procedure was exported 27 times, varying single VisiTag parameters 30 
from default values. The presence of gaps in VisiTag markers (18 sectors) was assessed for each export and 31 
compared to gaps in CMR enhancement. 32 
Results: 33 
At default settings, VisiTag gaps were specific (97.5%) but less sensitive (50.4%) for CMR gaps. Sensitivity 34 
improved at higher thresholds (89.2% at 20g, 85.6% at 30sec, 88.5% Impedance 10Ω, 92.8% Temperature 35 
42°C), but with lower positive predictive value (42.3%, 42.7%, 41.1% and 37.7% respectively, versus 90.9% 36 
at baseline). ‘Force’ thresholds demonstrated stable PPV from 2-8g (p=0.24), but a rapid fall at forces >10g. 37 
Binomial logistic regression model explained 41.7% of gaps (χ2(4)=148, p<0.0001), correctly classifying 82% 38 
of cases (specificity 94.9%, sensitivity 56.8%).  39 
Conclusion: 40 
Gaps in VisiTags predict gaps in CMR LGE enhancement with high specificity at default settings. Sensitivity 41 
may be improved using more stringent thresholds, but at the potential cost of unnecessary ablation, 42 
particularly when a force >10g is stipulated.  43 
Key Words 44 
Atrial fibrillation, cardiac magnetic resonance imaging, structural remodeling, atrial fibrosis, catheter 45 
ablation 46 
Introduction 47 
Catheter-myocardial contact is a key determinant of ablation lesion formation, with many studies 48 
demonstrating the importance of contact force (CF) technology in the determination of ablation lesion 49 
quality and size (1–5) . Real-time CF measurement and display using CF-sensing catheters provides 50 
immediate feedback to the operator, improving catheter positioning (6) and estimation of radiofrequency 51 
(RF) energy delivery (3). 52 
However, it has been recognized from the outset that absolute CF is only one of several factors 53 
contributing to RF lesion formation (7). Using electroanatomic mapping (EAM) systems, multiple 54 
parameters can be assessed simultaneously, including ablation time, catheter stability, impedance drop, 55 
and catheter tip temperature. Simple summative indices such as force time integral (FTI) have been 56 
shown to be associated with lesion formation (8), but there has been a drive towards more objective 57 
markers for predicting tissue injury. VisiTag (Biosense Webster, Diamond Bar, CA, USA) is a software 58 
module within the CARTO3 EAM system that was introduced in 2014 to permit quantification and display 59 
of RF-induced injury. It enables operators to select the values of a specified selection of parameters 60 
(including minimum CF, time at location, stability indices, impedance drop and temperature) that must be 61 
met in order for a VisiTag marker to be placed at the ablation location. As such, it is an objective marker 62 
of ablation parameters that is highly dependent upon operator-assigned thresholds.  63 
Ex-vivo (9) and pre-clinical work (10) has contributed to informed selection of VisiTag thresholds, but 64 
there remains a wide variation between clinical operators (11, 12). The marker is also ascribed a single 65 
location on the atrial shell, and operators must interpret the distribution of VisiTags in their assessment of 66 
the adequacy of contiguity of lesions. There is therefore a need for the quantification of predictive value 67 
of VisiTags for chronic atrial ablation lesion formation in the clinical setting. 68 
CMR imaging is the only currently available modality for non-invasive ablation lesion assessment, using 69 
late gadolinium enhancement (LGE) as a reproducible marker of fibrosis secondary to tissue injury (13). It 70 
must be recognized that the precise relationship between raw signal intensity on the LGE CMR image and 71 
histologically validated atrial ablation scar remains under investigation, and it is highly likely that all 72 
nuances of scar formation and density cannot be detected using a single technique. However, animal and 73 
human studies have demonstrated a strong correlation between ablation lesions and LGE signal intensity, 74 
as assessed histologically (10, 14) and by voltage mapping (15, 16), and therefore the technique is 75 
increasingly being used as a marker of mature ablation scar formation.  76 
This study aimed to identify the optimal threshold settings for VisiTag parameters during human atrial 77 
ablation to predict mature atrial ablation scar, as assessed using the robust surrogate marker of CMR LGE 78 
enhancement. 79 
Methods 80 
Study population 81 
Between March 2014 and September 2015, patients with a pre-procedural baseline CMR scan undergoing 82 
first-time ablation for AF were approached to join the study. Inclusion criteria included an ablation 83 
performed using the SmartTouch ablation catheter (Biosense Webster) and that the VisiTag module was 84 
activated for the entire ablation procedure. Exclusion criteria were a contraindication to further CMR 85 
imaging or prior allergic reaction to contrast agent. 24 patients in total were recruited. Subjects provided 86 
written and informed consent and returned for CMR scan assessment of atrial scar at 3 months. Baseline 87 
demographics and comorbidities were documented at the initial scan. The study was performed at St 88 
Thomas’ Hospital, London, UK and was approved by the UK Health Research Authority (NRES Committee 89 
for South London, reference 08/H0802/68). 90 
Ablation procedure 91 
Two operators performed all catheter ablation procedures under general anaesthesia using CARTO3 92 
(Biosense Webster)) EAM system. For patients with a diagnosis of PAF and in sinus rhythm, a point-by-93 
point wide area circumferential ablation (WACA) achieving pulmonary vein isolation (PVI) was performed 94 
using the SmartTouch catheter (Biosense Webster, 8Fr irrigated). Operators were blinded to VisiTag 95 
placement, with VisiTags not displayed during ablation, but real-time contact force measurements were 96 
displayed. Lesion sites were recorded manually. Target ablation parameters were >5g for at least 15 97 
seconds per stable RF delivery location, performed in temperature-control mode using a dragging 98 
technique. Power was 30W throughout except on the posterior wall, where it was limited to 25W. 99 
Procedural endpoint was defined as PV isolation confirmed by entry block (and exit block if PV capture 100 
could be achieved). For patients presenting with PersAF, a WACA was performed followed by additional 101 
ablation (mitral line, roof line, inferior LA and complex fractionated electrogram ablation) as a step-wise 102 
ablation (17).  103 
CMR imaging acquisition and image interrogation 104 
CMR imaging was performed on a 1.5T MR-scanner (Ingenia, Philips Healthcare, Best, Netherlands). A 3D 105 
LGE acquisition (3D inversion recovery spoiled gradient echo (LGE)) was performed at 30min after 106 
gadolinium injection (acquired resolution 1.3x1.3x4mm3) (18) and post-ablation atrial scar (PAAS) within 107 
the 3D LGE dataset was interrogated using a maximum intensity projection technique (3mm outside semi-108 
automated segmentation, 1mm inside segmentation) (13). This created a LA shell with projected signal 109 
intensities, indicating scar location. PAAS was thresholded using a histologically-validated value of 3.3 110 
standard deviations (SDs) above the blood pool (BP) mean (14). Further details of imaging and processing 111 
techniques are provided in the online supplement.  112 
VisiTag parameter survey 113 
A questionnaire regarding prevailing practice in the use of contact force settings was sent in September 114 
2015 to 35 UK centres performing AF ablation. The full set of questions with potential responses is 115 
presented in the online supplement. The responses were used to determine median ranges for the 116 
default VisiTag parameter settings (see below).  117 
VisiTag data export 118 
Ablation data was exported retrospectively, with location-specific VisiTag status ascribed directly by the 119 
CARTO3 system for each export with differing parameter settings. The default settings were selected 120 
based upon the median values of the UK survey (see Online Supplement) and each export varied only a 121 
single parameter from default values. A total of 27 export datasets were created for each subject, with 122 
the number of settings exported for each parameter weighted according to the perceived importance of 123 
the parameter in the UK survey (Table 1). Figure 1 illustrates the change in VisiTag distribution for a single 124 
subject with variation of ‘Force’ threshold alone; further examples are presented in the online 125 
supplement. 126 
Comparison of ablation and CMR shells 127 
The CARTO3 export datasets were processed using custom written Matlab software (MathWorks, MA, 128 
USA). For each subject, the LA shell was remeshed to create isotropic surfaces, and the 27 sets of VisiTag 129 
locations extracted. A 7.5mm search radius was defined for each triangle of the LA shell, and the surface 130 
triangles were binarised to those associated with a VisiTag marker (VisiTag ‘shadow’), and those that were 131 
not. The 7.5mm search radius was defined based upon anticipated maximum lesion radius of 4.5mm at 132 
30W and 10g force (19, 20), with the addition of the default “Range” threshold of 3mm. Shells were also 133 
generated with interrogation distances of 2.5, 5, and 10mm in order to test the lesion radius assumption. 134 
At 2.5mm and 5mm interrogation distance there were gaps in >90% of segments at standard parameters, 135 
which was felt to be implausible given the acute electrical isolation of all veins at the end of the 136 
procedure. At 10mm, there were no gaps except at the most stringent of parameter settings.  137 
In order to facilitate comparison between CMR and ablation data, the CMR shell was registered to the 138 
ablation shell using an iterative closest point technique, blinded to both ablation and MRI signal data (21). 139 
In order to exclude the possibility that native atrial scar may have been present at the site of VisTag gaps, 140 
the pre-ablation atrial shells were also reviewed at the same threshold of 3.3SD above BP mean. The 141 
average scar burden at this (relatively high) threshold was 1.5±1.4%, almost exclusively at the right upper 142 
pulmonary vein (respiratory navigator artefact) and the mitral valve annulus. Across the 24 subjects, there 143 
was no overlap of pre-ablation enhancement and gaps in VisiTag lesions at default settings.  144 
Lesion continuity assessment 145 
The presence of a gap in CMR LGE scar was assessed at each of 18 sectors for each patient shell. Eight 146 
sectors were defined circumferentially around each vein pair, with a ninth, inter-ostial sector also defined 147 
on each side. The presence of a gap in VisiTag ‘shadow’ was assessed in blinded fashion for each sector 148 
for the 27 parameter setting groups using Paraview (Kitware, New York, NY, USA). The ablation line was 149 
considered continuous in the absence of any gap >1mm, representing the absolute CMR resolution limit. 150 
Distances were measured as a straight line between closest points of lesion apposition, using the ‘Ruler’ 151 
tool in Paraview. For continuous VisiTag variables (‘Force’, ‘Time’, and ‘Percentage Time’), “thresholds” 152 
were defined as the most stringent parameter setting at which no gap in VisiTag ‘shadow’ was observed 153 
within a sector. ‘Range’ is not an ordinal scale variable, and therefore could not be analysed using this 154 
method (see Online Supplement). Instead, the total number of ‘Range’ thresholds settings that 155 
demonstrated continuous VisiTag ‘shadow’ (maximum 6 settings) was used as a surrogate summative 156 
index. 157 
Statistical methods 158 
Normally distributed continuous variables are presented as mean ± SD, and median with interquartile 159 
range (IQR) for non-normal distribution or non-continuous ordinal data. Statistics were analysed using 160 
SPSS Statistics (Version 22,  Armonk,  NY). For assessment of VisiTag accuracy for prediction of gaps in 161 
ablation scar, the locations of CMR-derived chronic scar were taken as the ‘gold standard’ indication of 162 
chronic lesion formation. Sensitivity and specificity of VisiTag ‘shadow’ prediction of CMR gaps was 163 
assessed using standard methods (outlined in Table 2) and used to derive receiver operator characteristic 164 
(ROC) curves. Within-patient differences for binary thresholding (impedance on/off, temp on/off) were 165 
compared using Wilcoxon matched-pairs signed rank test, and the non-parametric Friedman test was 166 
used for multi-setting parameters (force, time, range, percentage time).  167 
Results 168 
24 subjects were included in the study (Table 3).  169 
An example of the variation in VisiTag ‘shadow’ with changing thresholds is shown in Figure 2, and the 170 
results of the CMR gap assessment are shown in the upper row of Figure 3. Gaps in the thresholded CMR 171 
LGE scar were present in 33% of sectors in total, with significant regional variation (p<0.001). The inter-172 
ostial sector was ablated on the right in 13 patients (54%- 7 of whom (53%) had CMR gaps), and on the 173 
left in 9 patients (37%- 2 of whom (22%) had CMR gaps).  174 
The sectors in which the highest ‘Force’ VisiTag thresholds could be applied without gaps being 175 
demonstrated between VisiTags ‘shadows’ were generally within the right anterior and left posterior 176 
regions (middle row Figure 3). A slightly different pattern was observed for ‘Time’ thresholds, where the 177 
highest threshold was observed infero-anteriorly (lower row Figure 3).  Median ‘Percentage Time’ was 178 
80% in all sectors. 179 
The upper chart in Figure 4 demonstrates the overall accuracy of the VisiTags for detection of CMR gaps 180 
at default settings. There were gaps in the continuous VisiTag ‘shadow’ in 78 sectors (18%) (note that 181 
operators were blinded to VisiTags during ablation), and when a VisiTag ‘shadow’ gap was present it was 182 
very rare for there to be continuous CMR scar (low false positive rate, 7 (1.5%) of sectors, PPV 0.907). 183 
However, the false negative rate (no gap in VisiTag ‘shadow’ but gap on CMR) was higher (74 (17%) of 184 
sectors, NPV 0.791).  185 
Individual Parameters 186 
The ROC curves (Figure 4) demonstrate a significant relationship (p<0.0001) between a gap in VisiTag 187 
‘shadow’ and gap in CMR LGE for all four parameters.  188 
‘Force’: The number of sectors with VisiTag ‘shadow’ gaps increased significantly with increased threshold 189 
(66 sectors (15%) at 2g, 293 (67%) at 20g, (p<0.001). The sensitivity and specificity were 0.504 and 0.975 190 
respectively at 8g, 0.626 and 0.822 at 12g, and 0.892 and 0.385 at 20g. The positive predictive value (PPV) 191 
and negative predictive value (NPV) for prediction of CMR gaps are shown in Figure 5. The NPV improved 192 
steadily with increasing ‘Force’ threshold, but there is a discontinuity in the progression of PPV. PPV was 193 
static between 2g and 8g (0.909 and 0.907 respectively, p=0.24) then decreased rapidly to 0.539 at 14g 194 
(P<0.0001): any gaps in VisiTag ‘shadow’ when threshold was ≤8g were highly likely to be associated with 195 
a gap in CMR scar, but at higher VisiTag thresholds (≥12g) continuous CMR scar was often formed without 196 
continuous VisiTag ‘shadows’ having been achieved. 197 
‘Time’: VisiTag ‘shadow’ gaps also increased significantly with increased threshold (61 sectors (14%) at 198 
5sec, 279 (64%) at 30sec, p<0.001), but with a more linear response to changes in threshold (Figure 5, top 199 
right chart). Sensitivity and specificity were 0.410 and 0.985 at 5 seconds, and 0.856 and 0.418 200 
respectively at 30 seconds.  201 
‘Percentage Time’: The presence of gaps in VisiTag ‘shadows’ changed a smaller amount across the 202 
‘Percentage Time’ settings (71 sectors (16%) at 30%, 104 (24%) at 80%, p<0.001): the AUC predominantly 203 
represents the sensitivity and specificity of the default VisiTag parameters.  204 
‘Range’: The effect of alteration in the ‘Range’ threshold is more complex parameter and is not ordinal 205 
(see Supplementary Data). Perhaps counter-intuitively, regions of the atrium may be associated with a 206 
VisiTag at smaller (more stringent) range settings, but not at larger (more lenient) ranges when ablation 207 
energy is ascribed to a more distant location.  119 sectors (27%) had VisiTag ‘shadow’ gaps at 2mm, 77 208 
(17%) at 3mm, and 136 (33%) at 7mm. ‘Range’ demonstrated a peak in specificity at 3mm (0.975), with 209 
relatively stable sensitivity throughout (maximum 0.576 at 2mm, minimum 0.475 at 4mm).  210 
‘Target Temperature’: The implementation of the ‘Target Temperature’ resulted in VisiTag ‘shadow’ gaps 211 
increasing from 77 sectors (17%) to 342 sectors (79%), with a consequent improvement in sensitivity from 212 
0.489 to 0.928 at the cost of a much lower PPV (0.907 to 0.377, p<0.001). 213 
Impedance Drop’: this binary filter also increased gaps from 77 sectors (17%) to 299 sectors (69%), 214 
improving sensitivity (from 0.489 to 0.885) at the cost of a lower PPV (0.907 to 0.411, p<0.001). 215 
Predictive model  216 
A binomial logistic regression was performed to ascertain the effects of the ‘Force’, ‘Time’, ‘Target 217 
Temperature’ and ‘Impedance Drop’ thresholds on the likelihood of detection of CMR LGE scar gap. 218 
‘Percentage Time’ and ‘Range’ were excluded due to significant collinearity with default values, and 219 
complex distribution of non-ordinate values respectively. The logistic regression model was statistically 220 
significant, χ2(4)=148, p<0.0001. The model explained 41.7% (Nagelkerke R2) of the variance in scar 221 
formation and correctly classified 82% of cases. Specificity was 94.9% and sensitivity 56.8% at a cut-off 222 
value of 0.5. Of the four predictor variables, only ‘Force’ and ‘Time’ were statistically significant (Table 4). 223 
Discussion 224 
This study was designed to quantify the value of VisiTag markers in the prediction of gaps in CMR-225 
assessed ablation lesion sets following AF ablation, as a non-invasive marker of chronic scar formation, 226 
and to examine the impact of variations in thresholds of each parameter. The principal findings are as 227 
follows: 228 
1. VisiTag settings vary widely between operators 229 
2. At default settings, VisiTag ‘shadow’ gaps demonstrate an excellent specificity (97.5%) but poorer 230 
sensitivity (50.4%) in the prediction of CMR scar gaps 231 
3. ‘Force’: Higher VisiTag thresholds (>10g) are associated with slightly higher NPV but lower specificity 232 
and poorer PPV: scar is frequently created at lower CF 233 
4.  ‘Target Temperature’ and ‘Impedance Drop’: the implementation of these filters at these settings 234 
(42°C and 10 Ω respectively) increases the NPV for gaps, but at the cost of higher false positive rate. 235 
Contact force 236 
There is evidence for the improvement in procedural outcomes with the use of contact force 237 
technologies. Leading on from early benchmark clinical studies (TOCCATA study (2) and EFFICAS I (3)), 238 
meta-analysis has demonstrated the benefit of operator feedback of real-time CF. Use of CF technology is 239 
associated with reduced ablation time, reduced total procedural time and perhaps a reduced risk of 240 
recurrence (5, 22), but the findings have not been reproduced universally in carefully designed 241 
randomised studies (23, 24). 242 
However, the target CF for creation of permanent, transmural lesions in the atrium remains unclear. The 243 
EFFICAS I study was the first to propose firm recommendations, suggesting that a target CF of >20g and 244 
FTI >400gs was associated with a reduced risk of electrical reconnection at 3 months on invasive testing. 245 
These targets were used in the subsequent EFFICAS II study, which reported a consequentially improved 246 
durability of PV isolation at three months (98%, compared to 81% in EFFICAS I) (25). Most other studies, 247 
though, have not stipulated a target CF, in the context of increased risk of complications with high CF (4). 248 
SMART-AF showed that clinical outcome was improved when ≥80% of ablation lesions were performed 249 
within ‘user-defined’ target ranges (overall average CF 17.9±9.4g), whilst TOCCASTAR noted that ablation 250 
effectiveness improved from 58% to 76% with the use of ‘optimal CF’, defined as ≥90% of lesions created 251 
with CF ≥10g. Such findings are difficult to implement clinically, and may suggest that consistent catheter 252 
control, rather than CF alone, is also a strong determinant of effective and contiguous lesion formation. 253 
Further studies have suggested that more conservative CF levels may be safer and equally efficacious. 254 
Pre-clinical work by Williams et al (10) found no difference in chronic atrial lesion formation using high CF 255 
(22.6±11.4g) versus low CF (7.8±4.0g), validated on LGE imaging, chronic voltage mapping and histology. 256 
In patients, Kimura et al (26) found no improvement in ablation, in terms of residual acute electrical 257 
connection, for CFs between 10-15g versus ≥15g. Furthermore, SMART-AF found an increased rate of 258 
procedural major adverse events with CF ≥ 14g, and Chelu and colleagues recently demonstrated 259 
increased oesophageal enhancement with CF >12g (27). 260 
In this context, the findings of this study are highly relevant. The fixing of ‘Time’, ‘Range’ and ‘Percentage 261 
Time’ thresholds controls for variation in catheter stability on assessment of the impact of CF. Here, the 262 
specificity of gaps between VisiTags for prediction of CMR scar gaps was unchanged between 2 and 8g, 263 
but then fell markedly at higher CF, suggesting that chronic scar was frequently formed at lower CF. 264 
However, the sensitivity and negative predictive value of VisiTag gaps did continue to improve marginally 265 
with increasing CF ≥10g. The selection of a CF threshold is, unsurprisingly, a trade-off between confidence 266 
in efficacy and safety. However, this study quantifies the diminishing benefit of increasing thresholds 267 
above 12g. 268 
Ablation time 269 
Increased total ablation time and FTI have been shown to be associated with improved ablation efficacy 270 
(3, 28), and increased chronic scar formation on CMR imaging (8), but no clinical studies have clearly 271 
dissociated the effect of time from force. There is a suggestion that the effect of RF energy on chronic 272 
lesion formation may begin to plateau above FTI values of 500gs (28) or total 20seconds of effective 273 
ablation (9). In this study there was improved sensitivity for lesion gaps when increasing time thresholds 274 
up to 30 seconds, with no significant plateau of specificity, in contrast to ‘Force’ thresholds. The FTI was 275 
not formally assessed on account of the complex interplay with the ‘Range’ parameter (see 276 
Supplementary Figure 8). However, at the highest ‘Force’ and ‘Time’ thresholds (20g or 30sec), minimum 277 
FTIs were approximately 200gs and 300gs respectively, and FTI exceeded 1000gs at <1% of VisiTags at 278 
default settings.  279 
Other parameters 280 
Alteration of ‘Range’ and ‘Percentage Time’ thresholds demonstrated only a minor impact upon VisiTag 281 
performance. ‘Range’ reflects the distance the catheter is allowed to travel before ablation indices are 282 
allocated to a separate VisiTag marker. The decrease in number of markers at higher ‘Range’ thresholds 283 
reflects the increased area that the marker represents, despite the increased leniency of the marker 284 
threshold. The peak number of markers at 3mm (see Online Supplement) suggests that this may be a 285 
suitable setting to capture both catheter stability and ablation location. 286 
‘Percentage Time’ reflects a rolling average of the amount of time that the CF has been greater than the 287 
minimum stipulated force, and as such it would be anticipated to be a marker of catheter stability. 288 
However, on assessment of the data in this study the ‘Percentage Time’ was found to be >80% for the 289 
vast majority of lesions, and therefore it has proved an ineffective filter at default ‘Force’ 8g. At higher 290 
target CF it may become a more discriminant index of catheter stability. 291 
‘Target Temperature’ and ‘Impedance Drop’ filters are used by few operators (11, 12), but they clearly 292 
improve discrimination in terms of NPV. It may be most appropriate that the filters are not used during 293 
ablation, but only for retrospective review of ablation parameters. In view of the limited implementation 294 
of the filters, only a single filter setting was assessed. They may warrant further assessment in the future 295 
(see supplementary Figures 9 and 10). 296 
CMR imaging assessment of chronic scar 297 
LGE CMR techniques have been shown to be a valid and reproducible (13) assessment of chronic ablation 298 
scar injury, associated with clinical outcome measures (14–16, 29–31). There is also corroborative 299 
evidence that the qualitative correlation between ablation indices and CMR-derived scar is strong. Andreu 300 
et al (32) demonstrated a strong relationship between minimum CF and visual assessment of location of 301 
gaps in CMR-derived scar. At a CF of >12g there was >94% specificity in prediction of an uninterrupted 302 
ablation line in one of the 18 PV segments, but there was no control for the impact of time or catheter 303 
stability.  304 
Limitations 305 
The use of the LGE as the gold standard for scar formation is a technique that has been shown to be 306 
specific to the presence of scar, but with lower sensitivity (16, 33). Despite the implementation of best-307 
practice imaging (18) and interrogation techniques, LGE may have missed scar where it was in fact 308 
present, and this would imply that lower thresholds than those identified may be effective. There is also 309 
the possibility of mis registration of the CMR to EAM shell: the impact of the registration was minimized 310 
through the use of a segment-by-segment analysis, but there remains the possibility of ascribing ablation 311 
or CMR enhancement to the wrong segment at the segment margins. Furthermore, as per common 312 
clinical practice, the VisiTag size for analysis was not varied with the parameters, but it is highly likely that 313 
the true lesion size increases on average with more stringent VisiTag parameters. All ablation procedures 314 
were clinical ablations, aiming for a uniform target force of >5g for at least 15seconds, and therefore 315 
variability in ablation parameters was relatively restricted. Finally, VisiTag annotation does not take into 316 
account power delivery: this is certainly another important factor in lesion formation and may have varied 317 
more significantly using temperature-controlled ablation as in this study. Newer objective lesion 318 
annotation indices integrate this parameter (34), and further evaluation of outcome is required.  319 
Conclusion 320 
Markers (VisiTags) calculated on objective assessment of ablation parameters are predictive of chronic 321 
CMR enhancement on sector-by-sector assessment. Mature atrial ablation scar formation, as assessed 322 
using CMR LGE techniques,  increases in a non-linear fashion with increased contact force, and in a linear 323 
fashion with increased ablation time. The relationship with stability indices, ‘Percentage Time’ and ‘Range’ 324 
is more complex, with ‘Percentage Time’ having minimal impact on predictive value. This study provides a 325 
detailed clinical assessment of the impact of objective ablation parameter thresholds on CMR-derived 326 
atrial scar. It quantifies the relationship between sensitivity and specificity at each threshold, assisting 327 
informed clinician selection of threshold values. 328 
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  454 
Figure Legends 455 
Figure 1. VisiTag locations with variation of ‘Force’ (grams). Colouring of tags is according to FTI 456 
(force time interval) in gram.seconds. LIPV: left inferior pulmonary vein (PV), RIPV: right inferior 457 
PV, RSPV: right superior PV, LIPV: left inferior PV. 458 
Figure 2. Example of the impact of ‘Force’ threshold alteration. CMR signal intensity (blue-red shell, scar in 459 
red) with VisiTag locations overlaid in grey ‘shadow’ at varying thresholds (2-20grams). Note over-460 
estimation of lesion formation compared to chronic scar at low threshold (low sensitivity for gaps), and 461 
underestimation of scar formation (low specificity for gaps) at high thresholds. 462 
Figure 3. (Top) Regional distribution of gaps in CMR LGE scar across all subjects. (Middle and lower) 463 
Highest thresholds that could be applied in each sector without gaps being demonstrated within VisiTag 464 
‘shadows’ for ‘Force’ (middle- in grams) and ‘Time’ (lower- in seconds). Values are median with 465 
interquartile range (IQR). For sector 9 (inter-ostial) – CMR gaps (upper) is percentage of all subjects, 466 
regardless of whether ablation was performed, but in middle and lower plots, values reflect only subjects 467 
in whom inter-ostial ablation was performed. LS: left superior pulmonary vein, LI: left inferior, RS: right 468 
superior, RI: right inferior. 469 
Figure 4. Top panel: Frequency histogram demonstrating false negative (FN), true negative (TN,) true 470 
positive (TP), and false positive (FP) frequencies for prediction of CMR scar gaps by gaps in VisiTag 471 
‘shadow’ at default settings (see text). Rows 2 and 3: Receiver operator characteristic (ROC) curves for 472 
prediction of CMR scar gaps by VisiTag ‘shadow’ gaps, over multiple thresholds. Bottom row: Frequency 473 
histograms demonstrating prediction of CMR scar gaps by gaps in VisiTag ‘shadow’ with activation of 474 
‘Imp’ or ‘Temp’ filters. AUC: area under curve. 475 
Figure 5. Negative predictive value (NPV) and positive predictive value (PPV) of a gap in VisiTag ‘shadow’ 476 
within each sector predicting a gap in continuous scar on CMR LGE. 477 
Tables 478 
	 Units	 Full	Description	 Number	of	settings	 Setting	values	 Default	value	
“Force”		 Grams		(g)	 Force	over	Time-	Minimum	Force	 10	 2-4-6-8-10-12-	14-16-18-20	 8	“Time”		 Seconds	(s)	 Stability	Minimum		Time	 6	 5-10-15-		20-25-30	 10	“Percentage		time”		 %	 Force	over	Time-	Time	(%)	 6	 30-40-50-		60-70-80	 50	“Range”		 mm	 Stability	Maximum		Range	 6	 2-3-4-5-6-7	 3	“Imp”		 Ohms	(Ω)	 Impedance	Drop	 2	 on	(10Ω),		off	 Off	“Temp”		 Celsius	(°C)	 Target	Temperature	 2	 on	(42°C),		off	 Off	












Table 2. Methods for determination of key indices of VisiTag performance. n(group) indicates the 480 
number of points within each subgroup.   481 
 	 All Subjects 
(n=24)	
Male	 18 (75%)	
Paroxysmal AF	 11 (61%)	
CHA2DS2VASC Score 	 1 (IQR 0-2)	
AF duration (years)	 3.0 (IQR 1.75-5.5)	
Age (years)	 62 ±11	
Weight (kg)	 88 ±20	
Height (cm)	 175 ±8	
BMI (kg/m2)	 28.9±6.7	
Max LA volume pre-ablation (ml)	 130±42	
Max LA volume at post-ablation scan (ml) 124±40 
Table 3. Summary of baseline demographics and scan characteristics. LA volume assessed using 482 




Significance	Lower	 Upper	‘Force’	(per	gram)	 1.14	 1.075	 1.208	 <0.0001	‘Time’	(per	second)	 1.054	 1.016	 1.093	 0.005	‘Target	Temperature’	 0.973	 0.443	 2.137	 0.946	‘Impedance	Drop’	 0.659	 0.341	 1.273	 0.214	Constant	 0.215	 	 	 0.009	
Table 4. Variables in equation: binomial logistic regression. CI: confidence interval. 485 
